These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18549925)

  • 1. Predicting the effectiveness of beta-blocker therapy in vasovagal syncope.
    Kapoor JR
    J Am Coll Cardiol; 2008 Jun; 51(24):2372; author reply 2372-3. PubMed ID: 18549925
    [No Abstract]   [Full Text] [Related]  

  • 2. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!
    Mathias CJ
    Clin Sci (Lond); 2006 Sep; 111(3):189-91. PubMed ID: 16848762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of tilting test negativization during beta-blocker treatment in patients with neurocardiogenic syncope.
    Vincenti A; Schena F; Cirò A; De Ceglia S
    Cardiologia; 1999 May; 44(5):461-8. PubMed ID: 10389353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasovagal syncope].
    Nellessen E; Melon P; Kulbertus H
    Rev Med Liege; 1997 May; 52(5):324-8. PubMed ID: 9273633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic changes during head-up tilt test and predictive value thereof in predicting the efficacy of metoprolol therapy in children with vasovagal syncope].
    Zhang QY; DU JB; Zhen JL; Li WZ; Wang YL
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1260-2. PubMed ID: 17686261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of pindolol for treatment of neurocardiogenic syncope.
    Nair N; Padder FA; Kutalek SP; Kantharia BK
    Am J Cardiol; 2004 Nov; 94(9):1189-91. PubMed ID: 15518620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
    Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
    J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodepressor syncope. Diagnosis and management.
    Barbey JT
    Cardiol Clin; 1997 May; 15(2):251-6. PubMed ID: 9164713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic blood pressure at rest, not the degree of beta blockade, predicts the result of follow-up tilt-table testing for vasovagal syncope.
    Lewis WR; Carlson MD
    Am J Cardiol; 1997 Aug; 80(3):351-3. PubMed ID: 9264436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of pindolol in neurocardiogenic syncope.
    Iskos D; Dutton J; Scheinman MM; Lurie KG
    Am J Cardiol; 1998 Nov; 82(9):1121-4, A9. PubMed ID: 9817494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
    Alegria JR; Gersh BJ; Scott CG; Hodge DO; Hammill SC; Shen WK
    Am J Cardiol; 2003 Jul; 92(1):82-4. PubMed ID: 12842256
    [No Abstract]   [Full Text] [Related]  

  • 13. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope.
    Eldadah BA; Pechnik SL; Holmes CS; Moak JP; Saleem AM; Goldstein DS
    Clin Sci (Lond); 2006 Sep; 111(3):209-16. PubMed ID: 16634720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of cerebral hypoperfusion as trigger of neurally-mediated vasovagal syncope.
    Abe H; Kohshi K; Kuroiwa A
    Pacing Clin Electrophysiol; 1998 Mar; 21(3):613-6. PubMed ID: 9558695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral syncope in a patient with spinal cord injury.
    Bisharat N; Paz E; Klimov A; Friedberg N; Elias M
    Pacing Clin Electrophysiol; 2002 Mar; 25(3):372-3. PubMed ID: 11990670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers no better than placebo in the treatment of vasovagal syncope.
    Phillips J; Krist A
    J Fam Pract; 2002 Nov; 51(11):921. PubMed ID: 12485542
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical symptoms, the diagnostics and the therapy of orthostatic intolerance].
    Semrád B
    Vnitr Lek; 2006 Feb; 52(2):113-4. PubMed ID: 16623270
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of head-up tilt test with intravenous beta-blocker administration in assessing the efficacy of therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Cholewa M
    Ann Noninvasive Electrocardiol; 2005 Jan; 10(1):65-72. PubMed ID: 15649240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of neurally mediated syncope induced by laughter successfully treated with combination of propranolol and midodrine.
    Amaki M; Kamide K; Takiuchi S; Niizuma S; Horio T; Kawano Y
    Int Heart J; 2007 Jan; 48(1):123-7. PubMed ID: 17379987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.